Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001683168-23-001127
Filing Date
2023-02-24
Accepted
2023-02-24 17:15:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 sonoma_424b5.htm 424B5 7183
2 GRAPHIC a1.jpg GRAPHIC 22456
  Complete submission text file 0001683168-23-001127.txt   39302
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 424B5 | Act: 33 | File No.: 333-250925 | Film No.: 23668657
SIC: 2834 Pharmaceutical Preparations